ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2026年一季度报告 | 2026-04-23 | Chinese | |
| 关于召开2025年度网上业绩说明会的公告 | 2026-04-03 | Chinese | |
| 关于第九届董事会第三次会议决议的公告 | 2026-04-02 | Chinese | |
| 关于聘任窦昌林博士为公司首席执行官兼首席科学家的公告 | 2026-04-02 | Chinese | |
| 关于续聘公司2026年度审计机构的公告 | 2026-03-30 | Chinese | |
| 独立董事2025年度述职报告（陈飞虎） | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36129714 | 2026年一季度报告 | 2026-04-23 | Chinese | ||
| 36129713 | 关于召开2025年度网上业绩说明会的公告 | 2026-04-03 | Chinese | ||
| 36129712 | 关于第九届董事会第三次会议决议的公告 | 2026-04-02 | Chinese | ||
| 36129711 | 关于聘任窦昌林博士为公司首席执行官兼首席科学家的公告 | 2026-04-02 | Chinese | ||
| 36129709 | 关于续聘公司2026年度审计机构的公告 | 2026-03-30 | Chinese | ||
| 36129708 | 独立董事2025年度述职报告（陈飞虎） | 2026-03-30 | Chinese | ||
| 36129706 | 独立董事2025年度述职报告（姚禄仕） | 2026-03-30 | Chinese | ||
| 36129705 | 2025年度内部控制评价报告 | 2026-03-30 | Chinese | ||
| 36129704 | 关于“质量回报双提升”行动方案的进展公告 | 2026-03-30 | Chinese | ||
| 36129703 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-30 | Chinese | ||
| 36129702 | 董事会对独立董事独立性评估的专项意见 | 2026-03-30 | Chinese | ||
| 36129701 | 独立董事2025年度述职报告（耿小平） | 2026-03-30 | Chinese | ||
| 36129699 | 2025年度董事会工作报告 | 2026-03-30 | Chinese | ||
| 36129698 | 关于回购注销部分限制性股票减资暨通知债权人的公告 | 2026-03-30 | Chinese | ||
| 36129697 | 关于召开2025年度股东会的通知 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIMMUNE CORPORATION
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.